Alex Thompson
Stock Analyst at Stifel
(3.72)
# 767
Out of 5,130 analysts
41
Total ratings
60.61%
Success rate
7.19%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Alex Thompson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASND Ascendis Pharma | Maintains: Buy | $254 → $256 | $202.99 | +26.11% | 4 | Dec 11, 2025 | |
| ARGX argenx SE | Maintains: Buy | $1,028 → $1,248 | $788.49 | +58.28% | 5 | Dec 11, 2025 | |
| ANAB AnaptysBio | Maintains: Buy | $80 → $56 | $44.67 | +25.36% | 2 | Dec 11, 2025 | |
| DNTH Dianthus Therapeutics | Maintains: Buy | $52 → $65 | $38.19 | +70.20% | 2 | Sep 12, 2025 | |
| TVTX Travere Therapeutics | Maintains: Hold | $20 → $25 | $34.58 | -27.70% | 4 | Sep 12, 2025 | |
| CGEM Cullinan Therapeutics | Reinstates: Buy | $22 | $10.90 | +101.83% | 1 | Jun 11, 2025 | |
| KYMR Kymera Therapeutics | Reinstates: Buy | $55 | $74.77 | -26.44% | 1 | May 20, 2025 | |
| AVTX Avalo Therapeutics | Initiates: Buy | $36 | $16.95 | +112.39% | 1 | Mar 25, 2025 | |
| CRNX Crinetics Pharmaceuticals | Initiates: Buy | $60 | $53.25 | +12.68% | 1 | Mar 25, 2025 | |
| ORKA Oruka Therapeutics | Initiates: Buy | $49 | $27.86 | +75.88% | 1 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $36 → $54 | $30.61 | +76.41% | 2 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $6 → $2 | $13.81 | -85.52% | 5 | Dec 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $66 → $69 | $18.49 | +273.17% | 2 | Dec 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $2 → $1 | $2.64 | -62.12% | 4 | Dec 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $31.73 | +26.06% | 2 | Sep 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $320 | $33.62 | +851.81% | 1 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $34 | $26.03 | +30.62% | 2 | Jul 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $33 | $1.32 | +2,400.00% | 1 | Dec 14, 2022 |
Ascendis Pharma
Dec 11, 2025
Maintains: Buy
Price Target: $254 → $256
Current: $202.99
Upside: +26.11%
argenx SE
Dec 11, 2025
Maintains: Buy
Price Target: $1,028 → $1,248
Current: $788.49
Upside: +58.28%
AnaptysBio
Dec 11, 2025
Maintains: Buy
Price Target: $80 → $56
Current: $44.67
Upside: +25.36%
Dianthus Therapeutics
Sep 12, 2025
Maintains: Buy
Price Target: $52 → $65
Current: $38.19
Upside: +70.20%
Travere Therapeutics
Sep 12, 2025
Maintains: Hold
Price Target: $20 → $25
Current: $34.58
Upside: -27.70%
Cullinan Therapeutics
Jun 11, 2025
Reinstates: Buy
Price Target: $22
Current: $10.90
Upside: +101.83%
Kymera Therapeutics
May 20, 2025
Reinstates: Buy
Price Target: $55
Current: $74.77
Upside: -26.44%
Avalo Therapeutics
Mar 25, 2025
Initiates: Buy
Price Target: $36
Current: $16.95
Upside: +112.39%
Crinetics Pharmaceuticals
Mar 25, 2025
Initiates: Buy
Price Target: $60
Current: $53.25
Upside: +12.68%
Oruka Therapeutics
Oct 11, 2024
Initiates: Buy
Price Target: $49
Current: $27.86
Upside: +75.88%
Mar 26, 2024
Reiterates: Buy
Price Target: $36 → $54
Current: $30.61
Upside: +76.41%
Dec 18, 2023
Maintains: Hold
Price Target: $6 → $2
Current: $13.81
Upside: -85.52%
Dec 18, 2023
Maintains: Buy
Price Target: $66 → $69
Current: $18.49
Upside: +273.17%
Dec 18, 2023
Maintains: Hold
Price Target: $2 → $1
Current: $2.64
Upside: -62.12%
Sep 13, 2023
Reiterates: Buy
Price Target: $40
Current: $31.73
Upside: +26.06%
Aug 9, 2023
Initiates: Buy
Price Target: $320
Current: $33.62
Upside: +851.81%
Jul 18, 2023
Maintains: Buy
Price Target: $28 → $34
Current: $26.03
Upside: +30.62%
Dec 14, 2022
Initiates: Buy
Price Target: $33
Current: $1.32
Upside: +2,400.00%